$DSGN
$DSGN
Design Therapeutics
Biotechnology company developing Gene-TAC small molecules to treat serious nucleotide repeat expansion diseases.
Stocks
$< 0.001
0
$0.00
Design Therapeutics Metrics
Metric
Show % of Total
Tokenized Public Stocks
10 TotalRWA.xyzAll Rights Reserved